Long-Term Liabilities: The sum of all non-current liabilities.
Oric Pharmaceuticals, Inc. (ORIC) had Long-Term Liabilities of $4.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-30.50M |
|
-- |
|
-- |
|
$34.55M |
|
$-34.55M |
|
$4.05M |
|
$-30.50M |
|
$-30.50M |
|
$-30.50M |
|
$-30.50M |
|
$-30.50M |
|
$-30.50M |
|
$-34.55M |
|
$-34.47M |
|
87.79M |
|
87.79M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$288.47M |
|
$2.42M |
|
$120.42M |
|
$408.89M |
|
$20.42M |
|
-- |
|
|
Long-Term Liabilities |
$4.11M |
$24.53M |
|
$384.36M |
|
$384.36M |
|
$384.36M |
|
98.53M |
|
| Cash Flow Statement Financials | |
$-110.97M |
|
$-148.03M |
|
$245.26M |
|
$59.90M |
|
$46.16M |
|
$-13.74M |
|
$25.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-111.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.94% |
|
-7.94% |
|
-7.46% |
|
-7.94% |
|
$3.90 |
|
$-1.27 |
|
$-1.26 |
|